Louis V. Wollenberger

Array ( [id] => 7026595 [patent_doc_number] => 20050020523 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Modified antisense nucleotides complementary to a section of the human haras gene' [patent_app_type] => utility [patent_app_number] => 10/732218 [patent_app_country] => US [patent_app_date] => 2003-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5932 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20050020523.pdf [firstpage_image] =>[orig_patent_app_number] => 10732218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432331 [patent_doc_number] => 20040162255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Treatment of neurodegenerative disease through intracranial delivery of siRNA' [patent_app_type] => new [patent_app_number] => 10/721693 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12381 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20040162255.pdf [firstpage_image] =>[orig_patent_app_number] => 10721693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971660 [patent_doc_number] => 20050037370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/700884 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50673 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037370.pdf [firstpage_image] =>[orig_patent_app_number] => 10700884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7286785 [patent_doc_number] => 20040146902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Structural motifs and oligomeric compounds and their use in gene modulation' [patent_app_type] => new [patent_app_number] => 10/700939 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40372 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146902.pdf [firstpage_image] =>[orig_patent_app_number] => 10700939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971660 [patent_doc_number] => 20050037370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Oligomeric compounds having modified bases for binding to adenine and guanine and their use in gene modulation' [patent_app_type] => utility [patent_app_number] => 10/700884 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50673 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037370.pdf [firstpage_image] =>[orig_patent_app_number] => 10700884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7375371 [patent_doc_number] => 20040219671 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'RNA interference mediated treatment of parkinson disease using short interfering nucleic acid (siNA)' [patent_app_type] => new [patent_app_number] => 10/698311 [patent_app_country] => US [patent_app_date] => 2003-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 58883 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219671.pdf [firstpage_image] =>[orig_patent_app_number] => 10698311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7374614 [patent_doc_number] => 20040219565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Oligonucleotides useful for detecting and analyzing nucleic acids of interest' [patent_app_type] => new [patent_app_number] => 10/690487 [patent_app_country] => US [patent_app_date] => 2003-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 90030 [patent_no_of_claims] => 184 [patent_no_of_ind_claims] => 87 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20040219565.pdf [firstpage_image] =>[orig_patent_app_number] => 10690487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803150 [patent_doc_number] => 07422853 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-09 [patent_title] => 'RNA interference using a universal target' [patent_app_type] => utility [patent_app_number] => 10/680449 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30152 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/422/07422853.pdf [firstpage_image] =>[orig_patent_app_number] => 10680449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7323454 [patent_doc_number] => 20040137429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => 'Therapeutic aptamers having binding specificity to gp41 of HIV' [patent_app_type] => new [patent_app_number] => 10/677807 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17145 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20040137429.pdf [firstpage_image] =>[orig_patent_app_number] => 10677807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 616303 [patent_doc_number] => 07144714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-05 [patent_title] => 'R2D2: an enzyme of RNA silencing' [patent_app_type] => utility [patent_app_number] => 10/670626 [patent_app_country] => US [patent_app_date] => 2003-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3887 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/144/07144714.pdf [firstpage_image] =>[orig_patent_app_number] => 10670626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 44457 [patent_doc_number] => 07777014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-17 [patent_title] => 'Functional correction of the -786C/T-variance of the human eNOS-gene' [patent_app_type] => utility [patent_app_number] => 10/527785 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11741 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/777/07777014.pdf [firstpage_image] =>[orig_patent_app_number] => 10527785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314278 [patent_doc_number] => 20040033980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Method of down-regulating gene expression' [patent_app_type] => new [patent_app_number] => 10/640898 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9540 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033980.pdf [firstpage_image] =>[orig_patent_app_number] => 10640898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5760692 [patent_doc_number] => 20060211637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Methods of down regulating target gene expression in vivo by introduction of interfering rna' [patent_app_type] => utility [patent_app_number] => 10/523714 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 6828 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20060211637.pdf [firstpage_image] =>[orig_patent_app_number] => 10523714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922185 [patent_doc_number] => 20060240425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Genes and polypeptides relating to myeloid leukemia' [patent_app_type] => utility [patent_app_number] => 10/530217 [patent_app_country] => US [patent_app_date] => 2003-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19120 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240425.pdf [firstpage_image] =>[orig_patent_app_number] => 10530217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470750 [patent_doc_number] => 20040102618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Human RNase H1 and oligonucleotide compositions thereof' [patent_app_type] => new [patent_app_number] => 10/616009 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 42059 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102618.pdf [firstpage_image] =>[orig_patent_app_number] => 10616009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7304259 [patent_doc_number] => 20040115690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Method of detecting inflammatory lung disorders' [patent_app_type] => new [patent_app_number] => 10/613105 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9810 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115690.pdf [firstpage_image] =>[orig_patent_app_number] => 10613105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7388880 [patent_doc_number] => 20040030111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Oligonucleotide directed misfolding of RNA' [patent_app_type] => new [patent_app_number] => 10/465730 [patent_app_country] => US [patent_app_date] => 2003-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16889 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0030/20040030111.pdf [firstpage_image] =>[orig_patent_app_number] => 10465730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7367453 [patent_doc_number] => 20040092470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Dry powder oligonucleotide formualtion, preparation and its uses' [patent_app_type] => new [patent_app_number] => 10/463999 [patent_app_country] => US [patent_app_date] => 2003-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 25061 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20040092470.pdf [firstpage_image] =>[orig_patent_app_number] => 10463999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275514 [patent_doc_number] => 20040234965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Novel pathways involved in epigenetic memory' [patent_app_type] => new [patent_app_number] => 10/444737 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16700 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234965.pdf [firstpage_image] =>[orig_patent_app_number] => 10444737 [rel_patent_id] =>[rel_patent_doc_number] =>)